RadNet Reports First Quarter Financial Results, Including Record First Quarter Revenue, Adjusted EBITDA(1) and Net Income, and Revises Upwards 2021 Financial Guidance Ranges

NEXT STORY
Revenue Cycle Management Market Size 2021 | Is Expected to Reach USD 258.16 Billion, Registering a CAGR of 13.0%
PREV STORY
Smart Immune Announces FDA Orphan Drug Status, IND Acceptance and Fast-Track Designation to Commence Phase 1/2 Clinical Trial of Proprietary Allogeneic T cell Progenitor Product SMART 101 (ProTcell™) for AML and ALL
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma

author_avatar
NASDAQ Market News

Kura Oncology Initiates Registration-Directed Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinomas

– AIM-HN designed to enroll at least 59 patients with HRAS mutant HNSCC – ...

author_avatar
NASDAQ Market News

CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

author_avatar
NASDAQ Market News